Mergers & Acquisitions

  • November 04, 2025

    3 Firms Steer $1.45B Sale Of TriMas Aerospace

    Engineered products maker TriMas, advised by Jones Day, on Tuesday announced that it has agreed to sell its aerospace business to Goodwin Procter LLP-advised capital markets firm Tinicum LP in a $1.45 billion all-cash deal.

  • November 04, 2025

    Novo Nordisk Boosts Metsera Bid To $10B After Pfizer Suit

    Metsera Inc. said Tuesday its board has determined that a sweetened offer from Novo Nordisk is a superior proposal to its existing merger agreement with Pfizer Inc., as the pharmaceutical takeover battle continues amid revised bids and a pending lawsuit.

  • November 04, 2025

    Pfizer Can't Freeze $9B Weight-Loss Drug Fight For Now

    A Delaware vice chancellor on Tuesday declined for the moment Pfizer Inc.'s emergency request to put Novo Nordisk's $9 billion bid for Metsera Inc. on hold, saying the time isn't yet at hand for the court's intervention in a fight for control of the developer of GLP-1 weight-loss drugs.

  • November 04, 2025

    2 Firms Advise CBRE's $1.2B Pearce Services Deal

    Real estate services firm CBRE Group Inc. announced Tuesday that it acquired Pearce Services LLC, a service provider for electromechanical infrastructure in North America, from New Mountain Capital in a $1.2 billion deal guided by Sullivan & Cromwell LLP and Ropes & Gray LLP.

  • November 04, 2025

    2 Firms Guide $800M Intuitive-Lanteris Spacecraft Deal

    Intuitive Machines Inc., a space technology and infrastructure services company, said Tuesday it has agreed to acquire Lanteris Space Systems from Advent International for $800 million in a deal steered by Simpson Thacher & Bartlett LLP and Weil Gotshal & Manges, respectively.

  • November 04, 2025

    Blackstone Injecting $700M Into Merck Cancer Therapy

    Merck & Co. said Tuesday it will receive $700 million from Blackstone Life Sciences to help fund development of sacituzumab tirumotecan, an experimental antibody-drug conjugate targeting TROP2, a protein found on many cancer cells.

  • November 04, 2025

    5 Firms Steer Denny's $620M Go-Private Deal

    At least five law firms are helping to steer Denny's Corp.'s new agreement for the diner chain operator to go private through a $620 million sale to investment firms TriArtisan Capital Advisors and Treville Capital Group and Denny's franchise operator Yadav Enterprises.

  • November 04, 2025

    Cinema Group To Buy US Rival Emagine For $105M

    Kinepolis Group NV said Tuesday it has agreed to acquire rival movie theater chain Emagine Entertainment's portfolio for $105 million, in a bid to significantly expand the Belgian group's presence in the sector.

  • November 04, 2025

    Linklaters Backs Apollo's $6.5B Deal For 50% Of Wind Project

    U.S. asset manager Apollo said it is paying $6.5 billion for a 50% stake in the world's largest wind project, owned by Denmark's Ørsted, to help fund the remaining construction costs.

  • November 03, 2025

    DOJ Taps Hall Render Atty As UnitedHealth Merger Monitor

    The U.S. Department of Justice asked a Maryland federal judge Monday to appoint a Hall Render Killian Heath & Lyman PC shareholder as compliance monitor as part of the settlement allowing UnitedHealth Group's merger with Amedisys.

  • November 03, 2025

    CMA Rejects Fix For Getty-Shutterstock Deal, Deepens Probe

    The U.K.'s competition enforcer rejected a package of fixes on Monday aimed at curing competition concerns raised by Getty Images' planned $3.7 billion merger with Shutterstock and launched an in-depth review of the visual content deal.

  • November 03, 2025

    Diamondhead Trustee Gets OK For Jan. Real Estate Sale

    A Delaware bankruptcy judge on Monday gave the trustee overseeing the Chapter 7 of casino developer Diamondhead Casino Corp. the go-ahead to put the vacant proposed casino site on the auction block in January.

  • November 03, 2025

    Chancery Considers Reviewing Icahn's Illumina Settlement

    A Delaware Chancery Court hearing on resolving class and derivative claims over Illumina fiduciary data breaches connected to the company's $8 billion acquisition of Grail Inc. was sidelined Monday by questions over a private settlement.

  • November 03, 2025

    Pfizer Hits Novo Nordisk In Fed. Court Over $9B Metsera Deal

    Pfizer Inc. moved its merger battle with Novo Nordisk into Delaware federal court Monday, accusing the Danish drugmaker of orchestrating an unfair deal to put a "stranglehold" on the fast-growing American GLP-1 weight-loss drug market.

  • November 03, 2025

    5 Firms Build Merger That Creates $7B Precious Metals Biz

    Metals producer Coeur Mining Inc. on Monday announced plans to acquire Canadian-focused intermediate mining company New Gold Inc. in a deal that boasts a total equity value of roughly $7 billion and was built by five law firms.

  • November 03, 2025

    Compass Says Zillow Ban Update Proves Its Point

    Real estate brokerage Compass Inc. told a New York federal court Friday that an update on Zillow's website regarding its implementation of an allegedly anticompetitive policy only provides further support for its request to block the policy, days ahead of a preliminary injunction hearing.

  • November 03, 2025

    DOJ Probes Nexstar's $6.2B Deal For Tegna

    The U.S. Department of Justice has requested additional information about Nexstar's planned $6.2 billion purchase of rival broadcast company Tegna, extending a waiting period that gives enforcers time to review the merger's impact on competition.

  • November 03, 2025

    2 Firms Guide Eaton's $9.5B Data Center Cooling Push

    Power management company Eaton Corp., based in Ireland with major U.S. operations, announced Monday it will buy the Boyd Thermal business from Boyd Corp. for $9.5 billion, deepening its push into data center infrastructure amid rising demand for power and efficiency.

  • November 03, 2025

    CompoSecure, Husky Technologies To Merge, Form $7.4B Biz

    Paul Weiss Rifkind Wharton & Garrison LLP-advised CompoSecure, which makes metal payment cards, on Monday unveiled plans to merge with Husky Technologies Ltd., led by Latham & Watkins LLP, in a deal that will value the combined business at roughly $7.4 billion.

  • November 03, 2025

    Bernstein Litowitz, Robbins Geller To Lead $8.9B Class Action

    The Delaware Chancery Court has tapped Bernstein Litowitz Berger & Grossmann LLP and Robbins Geller Rudman & Dowd LLP to lead stockholder litigation over an $8.9 billion take-private deal, citing the firms' alignment with institutional investors holding the largest stake.

  • November 03, 2025

    Latham Adds Private Equity Firm's Veteran GC In Houston

    Latham & Watkins LLP has grown its mergers and acquisitions and private equity practice in the Lonestar State with the addition of the longtime general counsel for private equity firm The Sterling Group, the firm said Monday.

  • November 03, 2025

    Catching Up With Delaware's Chancery Court

    From billion-dollar pharma feuds to shifting equity deadlines, Delaware's courts saw another week of battles over mergers, fiduciary duty and judicial limits.

  • November 03, 2025

    Kirkland, Gibson Dunn Lead $12.8B SM Energy, Civitas Merger

    Independent energy company SM Energy, advised by Gibson Dunn & Crutcher LLP, and fellow energy company Civitas Resources, led by Kirkland & Ellis LLP, on Monday announced plans to merge in an all-stock deal that gives the combined company an enterprise value of $12.8 billion.

  • November 03, 2025

    Amazon, OpenAI Ink $38B Compute Infrastructure Deal

    Amazon Web Services said Monday it has entered into a seven-year, $38 billion strategic partnership with OpenAI to provide computing infrastructure that will run and scale the ChatGPT maker's core artificial intelligence workloads.

  • November 03, 2025

    4 Firms Guide $48.7B Kimberly-Clark Deal For Kenvue

    Huggies maker Kimberly-Clark Corp. announced Monday it will acquire Tylenol parent company Kenvue at an enterprise value of approximately $48.7 billion, with four firms steering the transaction. 

Expert Analysis

  • Series

    Playing Baseball Makes Me A Better Lawyer

    Author Photo

    Playing baseball in college, and now Wiffle ball in a local league, has taught me that teamwork, mental endurance and emotional intelligence are not only important to success in the sport, but also to success as a trial attorney, says Kevan Dorsey at Swift Currie.

  • Building Better Earnouts In The Current M&A Climate

    Author Photo

    In the face of market uncertainty, we've seen a continued reliance on earnouts in M&A deals so far this year, but to reduce the risk of related litigation, it's important to use objective standards, apply company metrics cautiously and ensure short time periods, among other best practices, say attorneys at White & Case.

  • Series

    Law School's Missed Lessons: Skillful Persuasion

    Author Photo

    In many ways, law school teaches us how to argue, but when the ultimate goal is to get your client what they want, being persuasive through preparation and humility is the more likely key to success, says Michael Friedland at Friedland Cianfrani.

  • A Look At Trump 2.0 Antitrust Enforcement So Far

    Author Photo

    The first six months of President Donald Trump's second administration were marked by aggressive antitrust enforcement tempered by traditional structural remedies for mergers, but other unprecedented actions, like the firing of Federal Trade Commission Democrats, will likely stoke heated discussion ahead, says Richard Dagen at Axinn.

  • Litigation Inspiration: How To Respond After A Loss

    Author Photo

    Every litigator loses a case now and then, and the sting of that loss can become a medicine that strengthens or a poison that corrodes, depending on how the attorney responds, says Bennett Rawicki at Hilgers Graben.

  • The Metamorphosis Of The Major Questions Doctrine

    Author Photo

    The so-called major questions doctrine arose as a counterweight to Chevron deference over the past few decades, but invocations of the doctrine have persisted in the year since Chevron was overturned, suggesting it still has a role to play in reining in agency overreach, say attorneys at Crowell & Moring.

  • Biotech Collaborations Can Ease Uncertainty Amid FDA Shift

    Author Photo

    As concerns persist that the U.S. Food and Drug Administration's reduced headcount will impede developments at already-strapped biotech companies, licensing and partnership transactions can provide the necessary funding and pathways to advance innovative products, say attorneys at Troutman.

  • Series

    Playing Mah-Jongg Makes Me A Better Mediator

    Author Photo

    Mah-jongg rewards patience, pattern recognition, adaptability and keen observation, all skills that are invaluable to my role as a mediator, and to all mediating parties, says Marina Corodemus.

  • Business Court Bill Furthers Texas' Pro-Corporate Strategy

    Author Photo

    The Texas Legislature's recent bill to enhance corporate protections and expand access to the Texas Business Court by refining its jurisdictional standards is just the latest step in the state's playbook for becoming the new center of corporate America, say attorneys at Katten.

  • FTC Staff Cuts Unlikely To Curb Antitrust Enforcement Agenda

    Author Photo

    While Federal Trade Commission Chair Andrew Ferguson's recent commitment to reducing agency staff may seem at odds with the Trump administration's commitment to antitrust enforcement, a closer analysis shows that such reductions have little chance of derailing the president's efforts, say attorneys at Squire Patton.

  • Series

    Law School's Missed Lessons: Navigating Client Trauma

    Author Photo

    Law schools don't train students to handle repeated exposure to clients' traumatic experiences, but for litigators practicing in areas like civil rights and personal injury, success depends on the ability to view cases clinically and to recognize when you may need to seek help, says Katie Bennett at Robins Kaplan.

  • Opinion

    4 Former Justices Would Likely Frown On Litigation Funding

    Author Photo

    As courts increasingly confront cases involving hidden litigation finance contracts, the jurisprudence of four former U.S. Supreme Court justices establishes a constitutional framework that risks erosion by undisclosed financial interests, says Roland Eisenhuth at the American Property Casualty Insurance Association.

  • Takeaways From EU's Review Of Merger Control Guidelines

    Author Photo

    The European Commission’s newly launched consultation on the European Union’s merger guidelines will explore whether and how merger control should consider key policy objectives, such as innovation, investment incentives and security, say lawyers at Latham.

  • How Attys Can Use AI To Surface Narratives In E-Discovery

    Author Photo

    E-discovery has reached a turning point where document review is no longer just about procedural tasks like identifying relevance and redacting privilege — rather, generative artificial intelligence tools now allow attorneys to draw connections, extract meaning and tell a coherent story, says Rose Jones at Hilgers Graben.

  • Identifying Data Center Investment Challenges, Opportunities

    Author Photo

    The role of data centers is expanding, as are new opportunities for private capital investors, but there are issues to consider, including finance models and contract complexity, as well as power supply, cyber threat resilience and data sovereignty, say lawyers at Ropes & Gray.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Mergers & Acquisitions archive.